| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
7 A single-cell method to detect early activation of the latent HIV provirus
|
Svensson, J.P.
|
|
|
3 |
S1 |
p. 8
|
article
|
| 2 |
16 A subset of bNAbs exhibit broad binding to primary CD4+ T cells infected with reactivated reservoir HIV in vitro
|
Ren, Yanqin
|
|
|
3 |
S1 |
p. 11-12
|
article
|
| 3 |
30 Changes in expression of small non-coding RNA during HIV infection and latency in a CD4+ T cell model of HIV latency
|
Vemula, SaiVikram
|
|
|
3 |
S1 |
p. 17-18
|
article
|
| 4 |
6 Epigenetic dysregulation of the major histocompatibility complex (MHC) region in HIV-infected children on early antiretroviral therapy
|
Shiau, Stephanie
|
|
|
3 |
S1 |
p. 7-8
|
article
|
| 5 |
25 Estimating the contribution of proliferation to HIV-infected lymphocyte persistence
|
Gerold, J.M.
|
|
|
3 |
S1 |
p. 15
|
article
|
| 6 |
18 Expanded clones in SIV-infected macaques on antiretroviral therapy recapitulate key features of expanded clones in HIV infection: implications for evaluation of ‘HIV cure’ interventions
|
Wu, Xiaolin
|
|
|
3 |
S1 |
p. 12-13
|
article
|
| 7 |
33 Experiences and expectations of participants completing HIV cure-focused clinical trials
|
McMahon, J.H.
|
|
|
3 |
S1 |
p. 18-19
|
article
|
| 8 |
2 Generation of new model systems for HIV infection to explore epigenetic effects of HIV integration site choice
|
Bialek, J.K.
|
|
|
3 |
S1 |
p. 6
|
article
|
| 9 |
31 High prevalence of CXCR4-using virus and low clonal expansion in infected naïve and central memory CD4+ T cells in individuals on ART
|
Roche, M.
|
|
|
3 |
S1 |
p. 18
|
article
|
| 10 |
10 Histone deacetylase inhibitors reduce proteins crucial to the elongation, splicing and nuclear export of HIV RNAs
|
Mota, Talia M.
|
|
|
3 |
S1 |
p. 9
|
article
|
| 11 |
27 HIV-associated gastrointestinal microbial dysbiosis influences the efficacy of anti-HIV immunity by immune checkpoint blockade
|
SahBandar, I.N.
|
|
|
3 |
S1 |
p. 16
|
article
|
| 12 |
19 HIV-1 Nef enhances viral reactivation and downregulates HLA class I: a dual role in modulating immune-mediated clearance of reservoirs
|
Kuang, XiaomeiT
|
|
|
3 |
S1 |
p. 13
|
article
|
| 13 |
3 HIV prevalence among patients from the Brazilian National Cancer Institute: a call for the relevance of HIV malignancies
|
Leal, Fabio E.
|
|
|
3 |
S1 |
p. 6-7
|
article
|
| 14 |
13 HIV-1-specific ADCC following anti-latency therapy and analytical treatment interruption
|
Lee, W.S.
|
|
|
3 |
S1 |
p. 10
|
article
|
| 15 |
24 HIV-specific, ex vivo expanded T cell therapy (HXTC) for HIV clearance: feasibility, safety and efficacy
|
Sung, Julia M.
|
|
|
3 |
S1 |
p. 15
|
article
|
| 16 |
29 Impact of adjunctive metformin therapy on T cell exhaustion and viral persistence in a clinical trial of HIV-infected adults on suppressive ART
|
Chew, G.M.
|
|
|
3 |
S1 |
p. 17
|
article
|
| 17 |
8 Implication of the HIV-1 pol gene intragenic enhancer in myeloid-specific viral gene expression
|
Verdikt, R.
|
|
|
3 |
S1 |
p. 8
|
article
|
| 18 |
5 Inhibition of HIV-1 gene transcription by KAP1: a new CTIP2 interactant
|
Ait Ammar, Amina
|
|
|
3 |
S1 |
p. 7
|
article
|
| 19 |
23 Knockdown of CCR5 expression in antigen-specific cytotoxic CD4 T cells
|
Zaunders, John
|
|
|
3 |
S1 |
p. 14-15
|
article
|
| 20 |
9 LEDGIN-mediated inhibition of the IN-LEDGF/p75 interaction reduces provirus reactivation from latency
|
Debyser, Zeger
|
|
|
3 |
S1 |
p. 9
|
article
|
| 21 |
11 Murine model to predict viral rebound in HIV+ allotransplanted subjects
|
Salgado, Maria
|
|
|
3 |
S1 |
p. 9-10
|
article
|
| 22 |
4 New HIV specific latency reversing agents with novel targets that synergise with HIV Tat and the bromodomain inhibitor, JQ1 to reactivate HIV from primary cells.
|
Jacobson, J.
|
|
|
3 |
S1 |
p. 7
|
article
|
| 23 |
OA5-1 Achievement of full donor chimerism with episodes of alloreactivity contributes to reduce the HIV reservoir after allogeneic stem cell transplantation
|
Salgado, M.
|
|
|
3 |
S1 |
p. 5
|
article
|
| 24 |
OA3-3 Anti-PD-1 disrupts HIV latency in non-proliferating but not in proliferating T cells
|
Van der Sluis, R.M.
|
|
|
3 |
S1 |
p. 4
|
article
|
| 25 |
OA4-1 Combined IL-21 and IFNα treatment limits residual inflammation, viral persistence and delays viral rebound in SIV-infected rhesus macaques
|
Micci, L.
|
|
|
3 |
S1 |
p. 4-5
|
article
|
| 26 |
OA1-2 Enrichment of the HIV reservoir in CD32+ CD4 T cells occurs early and is closely associated with immune checkpoint receptor expression
|
Martin, G.E.
|
|
|
3 |
S1 |
p. 1-2
|
article
|
| 27 |
OA4-2 Evaluation of different Treg depletion approaches as strategies for improved SIV reactivation and clearance
|
Sivanandham, R.
|
|
|
3 |
S1 |
p. 5
|
article
|
| 28 |
OA3-1 HIV reservoir dynamics and immune responses after anti-PD-1 therapy
|
Scully, E.
|
|
|
3 |
S1 |
p. 3
|
article
|
| 29 |
OA2-1 Identification of a new factor involved in DNA methylation-mediated repression of latent HIV-1
|
Bouchat, S.
|
|
|
3 |
S1 |
p. 2
|
article
|
| 30 |
OA1-1 Impact of vorinostat treatment of non-Hodgkin‘s lymphoma on HIV-1 latent reservoir
|
Capoferri, A.
|
|
|
3 |
S1 |
p. 1
|
article
|
| 31 |
OA2-2 Jak inhibitors employ novel mechanisms to block reservoir seeding and HIV persistence
|
Gavegnano, C.
|
|
|
3 |
S1 |
p. 2
|
article
|
| 32 |
OA3-2 PD-1 blockade in 12 HIV-infected patients with lung cancer
|
Samri, A.
|
|
|
3 |
S1 |
p. 3-4
|
article
|
| 33 |
OA2-3 Small-molecule chemotherapeutic drugs reactivate HIV-1 via non-canonical pathways and modulate CD8 T cell response
|
Munoz-Arias, I.
|
|
|
3 |
S1 |
p. 2-3
|
article
|
| 34 |
28 Optimised ART and alloBMT to reduce HIV reservoirs
|
Durand, Christine M.
|
|
|
3 |
S1 |
p. 16-17
|
article
|
| 35 |
1 Outcomes of cervical cancer among HIV-infected and uninfected women treated at the Brazilian National Institute of Cancer (2001–2013)
|
Ferreira, M.P.
|
|
|
3 |
S1 |
p. 6
|
article
|
| 36 |
21 Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo
|
Ward, Adam
|
|
|
3 |
S1 |
p. 13-14
|
article
|
| 37 |
32 Plasmacytoid DCs control HIV latency in resting T cells by type I IFNα
|
Van der Sluis, R.M.
|
|
|
3 |
S1 |
p. 18
|
article
|
| 38 |
17 Priming of tumour or HIV-specific human CD8+ T cells with superior functional properties using STING ligands
|
Papagno, Laura
|
|
|
3 |
S1 |
p. 12
|
article
|
| 39 |
15 Pulmonary T cells and HIV reservoirs in adults under suppressive ART
|
Costiniuk, CeciliaT
|
|
|
3 |
S1 |
p. 11
|
article
|
| 40 |
20 Rapid CTL recognition of HIV-1 latently infected cells depends on the levels of inducible viral reactivation and CTL activation status
|
Ruiz, A.
|
|
|
3 |
S1 |
p. 13
|
article
|
| 41 |
22 The HIV reservoir as a genetically heterogeneous archive of within-host viral evolution: implications for immunotherapeutic cure strategies
|
Jones, B.R.
|
|
|
3 |
S1 |
p. 14
|
article
|
| 42 |
12 The optimisation of antiviral RNAs for use in a gene therapy approach to cure HIV-1 infection
|
Del Corpo, Olivier
|
|
|
3 |
S1 |
p. 10
|
article
|
| 43 |
26 Towards an HIV functional cure with CAR-T cells: elucidating mechanisms underlying the extremely high potency of bispecific anti-HIV CARs designed for optimal activity and minimal immunogenicity
|
Ghanem, M.H.
|
|
|
3 |
S1 |
p. 15-16
|
article
|
| 44 |
14 Treatment with tyrosine kinase inhibitors make PBMCs from patients with chronic myeloid leukemia less susceptible to HIV-1 infection: control of CD4+ T cell activation to control HIV-1 replication
|
Bermejo, Mercedes
|
|
|
3 |
S1 |
p. 10-11
|
article
|
Journal description